Get started
Author

Antonella Bruzzese

Iron chelation therapy
2023 · Antonella Bruzzese, Enrica Antonia Martino, et al. · European Journal Of Haematology · 82
Peripherally inserted central catheters in allogeneic hematopoietic stem cell transplant recipients
2020 · Elena Mariggiò, Anna Paola Iori, et al. · Supportive Care in Cancer · 35
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions
2024 · Caterina Labanca, Enrica Antonia Martino, et al. · European Journal Of Haematology · 33
PDF
GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes
2020 · Antonella Bruzzese, Davide Leardini, et al. · Cancers · 30
PDF
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials
2023 · Massimo Gentile, Ernesto Vigna, et al. · Haematologica · 26
PDF
Teclistamab‐cqyv in multiple myeloma
2023 · Enrica Antonia Martino, Antonella Bruzzese, et al. · European Journal Of Haematology · 23
Rilzabrutinib for the Treatment of Immune Thrombocytopenia
2025 · Caterina Labanca, Enrica Antonia Martino, et al. · European Journal Of Haematology · 22
PDF
PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count
2020 · Maria Cristina Scamuffa, Salvatore Giacomo Morano, et al. · Journal of Thrombosis and Thrombolysis · 22
Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies
2024 · Enrica Antonia Martino, Antonella Bruzzese, et al. · Expert Opinion on Investigational Drugs · 21
Belantamab mafodotin in multiple myeloma
2023 · Enrica Antonia Martino, Antonella Bruzzese, et al. · Expert Opinion on Biological Therapy · 21
PDF
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
2022 · Antonella Bruzzese, Daniele Derudas, et al. · Hematological Oncology · 19
Avatrombopag for the Treatment of Immune Thrombocytopenia
2025 · Caterina Labanca, Ernesto Vigna, et al. · European Journal Of Haematology · 17
PDF
Selinexor in multiple myeloma
2024 · Enrica Antonia Martino, Ernesto Vigna, et al. · Expert Opinion on Pharmacotherapy · 17
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study
2025 · Enrica Antonia Martino, Daniele Derudas, et al. · Hematological Oncology · 16
Isatuximab in multiple myeloma
2023 · Enrica Antonia Martino, Antonella Bruzzese, et al. · Expert Opinion on Biological Therapy · 16
Elotuzumab in multiple myeloma
2022 · Antonella Bruzzese, Enrica Antonia Martino, et al. · Expert Opinion on Biological Therapy · 16
PDF
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials
2022 · Enrica Antonia Martino, Concetta Conticello, et al. · Hematological Oncology · 16
Cmv Management With Specific Immunoglobulins: a Multicentric Retrospective Analysis on 92 Allotransplanted Patients.
2019 · Michele Malagola, Raffaella Greco, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 16
PDF
Frailty predicts treatment-related toxicity and discontinuation in older adults with chronic lymphocytic leukemia treated with BTK and BCL-2 inhibitors: Findings from a prospective single-center cohort study
2025 · Enrica Antonia Martino, Ernesto Vigna, et al. · Journal of Geriatric Oncology · 14
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients
2025 · E.A. Martino, S. Palmieri, et al. · ESMO Open · 14
PDF
Vaccination in Multiple Myeloma: Challenges and Strategies
2025 · Enrica Antonia Martino, Ernesto Vigna, et al. · European Journal Of Haematology · 12
PDF
Treatment‐Free Remission in Chronic Myeloid Leukemia: Revisiting the “W” Questions
2025 · Antonella Bruzzese, Ernesto Vigna, et al. · European Journal Of Haematology · 12
PDF
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients
2021 · Fortunato Morabito, Elena Zamagni, et al. · European Journal Of Haematology · 11
PDF
TP53 ‐Mutated Acute Myeloid Leukemia: Unanswered Questions
2025 · Antonella Bruzzese, Ernesto Vigna, et al. · Hematological Oncology · 10
PDF
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
2025 · Giulio Caridà, Enrica Antonia Martino, et al. · European Journal Of Haematology · 10
PDF
Works count: 114
Citation count: 780
H-index: 16
I10-index: 27
Year
Topic
Type